Andrew Whelton Selected Research

rofecoxib (Vioxx)

5/2006	Effects of the selective cyclooxygenase-2 inhibitor analgesic celecoxib on renal carbonic anhydrase enzyme activity: a randomized, controlled trial.
1/2005	The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
11/2002	Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
10/2002	Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
10/2002	Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
9/2002	COX-2-specific inhibitors and the kidney: effect on hypertension and oedema.
6/2002	Physician-reported management of edema and destabilized blood pressure in cyclooxygenase-2-specific inhibitor users with osteoarthritis and treated hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew Whelton Research Topics

Disease

10	Hypertension (High Blood Pressure) 11/2017 - 02/2002
7	Gout 01/2022 - 01/2011
7	Osteoarthritis 11/2011 - 04/2002
6	Edema (Dropsy) 11/2011 - 02/2002
5	Arthritis (Polyarthritis) 01/2007 - 02/2002
4	Heart Failure 05/2006 - 02/2002
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2018 - 05/2006
2	Hyperuricemia 01/2018 - 11/2017
2	Pain (Aches) 11/2011 - 05/2006
2	Heart Diseases (Heart Disease) 05/2006 - 10/2002
2	Myocardial Infarction 09/2002 - 02/2002
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Thrombosis (Thrombus) 04/2010
1	Thrombocytopenia (Thrombopenia) 04/2010
1	Pulmonary Embolism 04/2010
1	Venous Thrombosis (Deep-Vein Thrombosis) 04/2010
1	Acute Kidney Injury (Acute Renal Failure) 05/2006
1	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2006
1	Acidosis 05/2006
1	Type 2 Diabetes Mellitus (MODY) 01/2005
1	Rheumatoid Arthritis 07/2004
1	Weight Gain 11/2002
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2002
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2002
1	Body Weight (Weight, Body) 04/2002
1	Essential Hypertension 04/2002
1	Stroke (Strokes) 02/2002

Drug/Important Bio-Agent (IBA)

9	Febuxostat FDA Link 01/2022 - 01/2011
9	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2006 - 02/2002
9	Celecoxib (Celebrex)FDA Link 05/2006 - 02/2002
7	rofecoxib (Vioxx)FDA Link 05/2006 - 06/2002
6	Uric Acid (Urate)IBA 01/2022 - 01/2011
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2006 - 04/2002
4	Naproxen (Naprosyn)FDA LinkGeneric 01/2005 - 10/2002
3	Xanthine OxidaseIBA 03/2018 - 11/2017
3	Pharmaceutical PreparationsIBA 01/2018 - 06/2002
3	DiureticsIBA 11/2011 - 06/2002
3	Antihypertensive Agents (Antihypertensives)IBA 11/2011 - 04/2002
3	Ibuprofen (Motrin)FDA LinkGeneric 07/2004 - 10/2002
3	Diclofenac (SR 38)FDA LinkGeneric 07/2004 - 10/2002
2	Allopurinol (Remid)FDA LinkGeneric 01/2022 - 03/2018
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2006 - 01/2005
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2002 - 04/2002
1	purineIBA 03/2018
1	lanthanum carbonate (Fosrenol)FDA Link 01/2018
1	AntithrombinsIBA 04/2010
1	Heparin (Liquaemin)FDA LinkGeneric 04/2010
1	desirudin (Iprivask)FDA Link 04/2010
1	argatroban (MPQA)FDA Link 04/2010
1	Cyclooxygenase InhibitorsIBA 01/2007
1	Acetaminophen (Paracetamol)FDA LinkGeneric 05/2006
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2006
1	ElectrolytesIBA 05/2006
1	ProstaglandinsIBA 05/2006
1	Non-Narcotic Analgesics (Analgesics, Non Narcotic)IBA 05/2006
1	AcidsIBA 05/2006
1	Acetazolamide (Diamox)FDA LinkGeneric 05/2006
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 05/2006
1	Bicarbonates (Hydrogen Carbonate)IBA 05/2006
1	valdecoxib (Bextra)FDA Link 07/2004
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2002
1	Lisinopril (Prinivil)FDA LinkGeneric 04/2002
1	CreatinineIBA 04/2002
1	PotassiumIBA 04/2002

Therapy/Procedure

7	Therapeutics 01/2013 - 06/2002
1	Aftercare (After-Treatment) 01/2022
1	Drug Therapy (Chemotherapy) 11/2011
1	Blood Pressure Monitors 11/2011
1	Surgical Amputation (Amputations) 04/2010
1	Analgesia 05/2006